Abstract
To the Editor: We greatly appreciated the article by Miller et al.1 In contrast to several studies showing a major role of brain natriuretic peptide (BNP) as a predictor of adverse prognosis in heart failure,2,3 the study by Miller et al reported that elevated BNP at baseline was not significantly associated with outcome (primary end point: death/cardiac transplantation) in a cohort of 190 patients with New York Heart Association class III-IV heart failure who were followed up for 24 months, after adjustment for troponin T levels, …
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
